Bangkok Today News reported that Atis Amrit is expanding its event presence in provincial hospitals, promoting immune system enhancement and improved blood circulation.
The company’s move comes as many areas of Thailand continue to experience high levels of PM2.5 particulate matter, prompting health experts to warn of the dangers beyond typical symptoms like coughing, sneezing, and eye irritation. Experts caution that PM2.5 can negatively impact the body’s immune system and circulatory system, which are vital for overall health.
According to reports, prolonged exposure to high PM2.5 levels can allow the particles to penetrate deep into the lungs, triggering inflammation throughout the body. This inflammation can disrupt immune balance, leading to fatigue, increased susceptibility to illness, and exacerbation of allergies. Inflammation can constrict blood vessels and impair circulation, particularly impacting vulnerable populations such as the elderly, children, and individuals with pre-existing health conditions.
Atis Amrit’s initiative focuses on providing support for immune system strengthening. The company recently received international recognition for its herbal-based immune support innovations. In July 2025, Atis Amrit was awarded a Gold Medal from the World Invention Intellectual Property Associations (WIIPA) at the JDIE 2025 event in Japan for its PhytoX extraction technology and Bioencap delivery system, which aims to deliver key ingredients to the cellular level. The company also received the NRCT Special Award for outstanding innovation from Thailand’s National Research Council.
“Atis Amrit” is led by Atichat Chummanan, the brand’s executive. The company’s efforts to promote immune health are occurring as Thailand seeks to establish itself as a leader in herbal medicine and innovation on the global stage.
